Long-Term Follow-up of a Randomized Study of Oral Etoposide versus Viscum album Fermentatum Pini as Maintenance Therapy in Osteosarcoma Patients in Complete Surgical Remission after Second Relapse

BACKGROUND: In relapsed osteosarcoma, the 5-yr postrelapse disease-free survival (PRDFS) rate after the second relapse is <20%. In June 2007, a randomized study was started comparing oral etoposide vs Viscum album fermentatum Pini (an extract derived from the parasitic plant Viscum album L., Euro...

Descripción completa

Detalles Bibliográficos
Autores principales: Longhi, Alessandra, Cesari, Marilena, Serra, Massimo, Mariani, Erminia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201820/
https://www.ncbi.nlm.nih.gov/pubmed/32398946
http://dx.doi.org/10.1155/2020/8260730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201820/
https://www.ncbi.nlm.nih.gov/pubmed/32398946
http://dx.doi.org/10.1155/2020/8260730

Ejemplares similares